CTLA4 and cervical carcinoma: Anti-CTLA-4 monoclonal antibodies or CTLA-4 vaccines constructions were developed in order to prevent CTLA-4 activities and it has been tested or are in ongoing trials for treatment of cervical cancer [14, 71, 72] and HNSCC [2, 13].